Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 151 to 200 of 502 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 0

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
151\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
u2 small nuclear ribonucleoprotein auxiliary factor 35 kda subunit related-protein 1. [source:swissprot;acc:q15695]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7502.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6461.83\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16098\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
152\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
similar to ribosomal protein, large, p0. [source:sptrembl;acc:q96fq9]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11438\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13277.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16079\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
153\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TUBG1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tubulin gamma-1 chain (gamma-1 tubulin) (gamma-tubulin complex component 1) (gcp-1). [source:swissprot;acc:p23258]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7879.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6789.92\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16044\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
154\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin va (myosin 5a) (dilute myosin heavy chain, non-muscle) (myosin heavy chain 12) (myoxin). [source:swissprot;acc:q9y4i1]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10883\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12622.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15986\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
155\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
REEP6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
polyposis locus protein 1-like 1; likely ortholog of mouse polyposis locus protein 1-like 1. [source:refseq;acc:nm\_138393]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12759.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11028.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15692\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
156\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TUB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tubby protein homolog. [source:swissprot;acc:p50607]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12303.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10641.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15618\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
157\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transcription initiation factor iie, beta subunit (tfiie-beta). [source:swissprot;acc:p29084]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
18079\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
15652\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15506\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
158\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NME2P1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
putative nucleoside diphosphate kinase (ec 2.7.4.6) (ndk) (ndp kinase). [source:swissprot;acc:o60361]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10060.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11616.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15469\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
159\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATG4B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cysteine endopeptidase aut-like isoform b. [source:refseq;acc:nm\_178326]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5813.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6706.32\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15361\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
160\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ccr4-not transcription complex, subunit 7 (ccr4-associated factor 1) (caf1) (btg1 binding factor 1). [source:swissprot;acc:q9uiv1]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11732\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13530.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15331\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
161\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATG4A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cysteine endopeptidase aut-like 2 isoform a; autophagy-related cysteine endopeptidase 2; autophagin 2. [source:refseq;acc:nm\_052936]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5781.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6660.63\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15197\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
162\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
putative eukaryotic translation initiation factor 1a (eif-1a) (eif- 4c). [source:swissprot;acc:o75642]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12301.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10680.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15176\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
163\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TFCP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transcription factor cp2; transcription factor cp2, alpha globin. [source:refseq;acc:nm\_005653]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8409.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9668.79\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14979\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
164\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
dihydrofolate reductase (ec 1.5.1.3). [source:swissprot;acc:p00374]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11971.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10412.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14975\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
165\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
ribose-phosphate pyrophosphokinase iii (ec 2.7.6.1) (phosphoribosyl pyrophosphate synthetase iii) (prs-iii). [source:swissprot;acc:p21108]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
13255.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
15183.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14544\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
166\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BOLA2B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
my016 protein. [source:sptrembl;acc:q9h3k6]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5561.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6366.91\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14488\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
167\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SRP9\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
signal recognition particle 9 kda protein (srp9). [source:swissprot;acc:p49458]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12157.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13890.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14252\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
168\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FOSL2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
fos-related antigen 2. [source:swissprot;acc:p15408]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7091.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6217.28\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14065\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
169\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GPT\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
alanine aminotransferase (ec 2.6.1.2) (glutamic--pyruvic transaminase) (gpt) (glutamic--alanine transaminase). [source:swissprot;acc:p24298]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9875.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11256.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13988\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
170\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FCER2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
low affinity immunoglobulin epsilon fc receptor (lymphocyte ige receptor) (fc-epsilon-rii) (cd23) (blast-2) (immunoglobulin e-binding factor). [source:swissprot;acc:p06734]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11364\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12941\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13877\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
171\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
lamin b2. [source:swissprot;acc:q03252]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12135.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13802\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13733\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
172\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SNAI2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger protein slug (neural crest transcription factor slug) (snail homolog 2). [source:swissprot;acc:o43623]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12225.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13893.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13638\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
173\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
suppressor of actin 1. [source:refseq;acc:nm\_014016]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
19088.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
16804.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13589\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
174\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
ribulose-5-phosphate-3-epimerase; ribulose 5-phosphate 3-epimerase. [source:refseq;acc:nm\_006916]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
13248.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
11666.4\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.13561\vspace{3pt}}}\\\cline{1-1}\cline{3-3}
\parbox{\wcA}{\vspace{3pt}\noindent
175\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
thiamin pyrophosphokinase 1; mouse thiamin pyrophosphokinase homolog; thiamine pyrophosphokinase. [source:refseq;acc:nm\_022445]\vspace{3pt}}&&&\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
176\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
dead-box protein abstrakt homolog. [source:swissprot;acc:q9ujv9]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
13068\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11528\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13359\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
177\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KCND2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
potassium voltage-gated channel, shal-related subfamily, member 2; voltage-sensitive potassium channel; voltage-gated potassium channel kv4.2. [source:refseq;acc:nm\_012281]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14922.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13174.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1327\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
178\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
integral membrane protein cii-3b. [source:sptrembl;acc:o75609]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14951.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13204.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13234\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
179\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MVK\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mevalonate kinase (ec 2.7.1.36) (mk). [source:swissprot;acc:q03426]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9473.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10723.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13203\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
180\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NOVA1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rna-binding protein nova-1 (neuro-oncological ventral antigen 1) (onconeural ventral antigen-1) (paraneoplastic ri antigen) (ventral neuron-specific protein 1). [source:swissprot;acc:p51513]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8407.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9516.92\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13193\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
181\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
importin 7; ran-binding protein 7. [source:refseq;acc:nm\_006391]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14864.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
16820.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13159\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
182\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NADK\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
putative inorganic polyphosphate/atp-nad kinase (ec 2.7.1.23) (poly(p)/atp nad kinase). [source:swissprot;acc:o95544]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11573.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10231.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13121\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
183\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
ubiquitin activating enzyme e1-like protein. [source:refseq;acc:nm\_006395]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11613\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13133.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13093\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
184\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
similar to zinc finger protein 277. [source:sptrembl;acc:q8wwa6]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6279.56\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
5569.42\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.12751\vspace{3pt}}}\\\cline{1-1}\cline{3-3}
\parbox{\wcA}{\vspace{3pt}\noindent
185\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger protein 277. [source:swissprot;acc:q9nrm2]\vspace{3pt}}&&&\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
186\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
40s ribosomal protein s2 (s4) (llrep3 protein). [source:swissprot;acc:p15880]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11935.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10592.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12672\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
187\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ADSSL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
adenylosuccinate synthase-like 1. [source:refseq;acc:nm\_152328]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9955.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11213.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12641\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
188\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RPL15\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l15. [source:swissprot;acc:p39030]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11745.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13203.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12413\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
189\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SALL4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sal-like protein 4 (zinc finger protein sall4). [source:swissprot;acc:q9ujq4]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10634.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9465\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12355\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
190\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
high-glucose-regulated protein 8 (ny-ren-2 antigen). [source:swissprot;acc:q9y5a9]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
18809.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
16764.2\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.122\vspace{3pt}}}\\\cline{1-1}\cline{3-3}
\parbox{\wcA}{\vspace{3pt}\noindent
191\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
sh3 adapter protein spin90 (sh3 protein interacting with nck, 90 kda) (vaca-interacting protein, 54 kda) (vip54) (af3p21) (diaphanous protein interacting protein) (dia interacting protein-1) (dip-1). [source:swissprot;acc:q9nzq3]\vspace{3pt}}&&&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
192\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CCT6A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
t-complex protein 1, zeta subunit (tcp-1-zeta) (cct-zeta) (cct-zeta-1) (tcp20) (htr3). [source:swissprot;acc:p40227]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12715.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11333.2\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
193\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GTF3A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transcription factor iiia (factor a) (tfiiia). [source:swissprot;acc:q92664]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10899.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12217.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12091\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
194\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
kappa b-ras 1. [source:refseq;acc:nm\_020345]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12657.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11299.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12024\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
195\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MRPS22\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mitochondrial 28s ribosomal protein s22 (s22mt) (mrp-s22) (gk002). [source:swissprot;acc:p82650]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
13942.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
15586.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11788\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
196\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
suppressor of ty 5 homolog; suppressor of ty (s.cerevisiae) 5 homolog. [source:refseq;acc:nm\_003169]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11064.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9897.84\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11784\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
197\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
importin 4. [source:refseq;acc:nm\_024658]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12337.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13788.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11763\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
198\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RPL10L\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ribosomal protein l10-like protein. [source:refseq;acc:nm\_080746]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11781.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10545.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11723\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
199\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l10 (qm protein) (tumor suppressor qm) (laminin receptor homolog). [source:swissprot;acc:p27635]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11781.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10545.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11721\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
200\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MTRF1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
peptide chain release factor 1, mitochondrial precursor (mrf-1). [source:swissprot;acc:o75570]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8786.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7870.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11644\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/